Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. (KPTI)

Market is closed
News
Looking Ahead To The Karyopharm Therapeutics Inc (KPTI) MM Data

Looking Ahead To The Karyopharm Therapeutics Inc (KPTI) MM Data

Karyopharm Therapeutics Inc (NASDAQ:KPTI) is set to report an overview of the topline data from its lead multiple myeloma trial on September 6 and markets are rallying in advance of good news.

Keep Reading →

August 31st, 2016 - News Stock Analysis

Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?

Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.

Keep Reading →

December 6th, 2015 - Hedge Funds News

Foresite Capital Management I Reveals 5.6% Position in Karyopharm Therapeutics

Foresite Capital Management I Reveals 5.6% Position in Karyopharm Therapeutics

Foresite Capital Management I disclosed, in a new filing with the SEC, a new passive stake in Karyopharm Therapeutics Inc (NASDAQ:KPTI), which amasses 5.6% of the company's common stock.

Keep Reading →

November 15th, 2013 - Hedge Funds News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)